
Pharma M&A remains quiet as China’s industry influence grows
The pharma industry is projected to see continued growth through 2030 — but not without sizable challenges along the way. By the end of the decade, global prescription drug sales are expected to top $1.75 trillion. However, historic changes are afoot for …